Bonviva (ibandronic acid): a new, once‐monthly bisphosphonate
Authors
Abstract
Bonviva is a new formulation of ibandronic acid that is taken once a month to treat osteoporosis. This New products review examines the trial data for its efficacy and how compliance may be improved. Copyright © 2006 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.446 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
